Halia Therapeutics, Inc.
New Form D on file · 2022-12-30 · the record
What the record says
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 716 filings in Biotechnology, totalled by week.
Company officers on record
Jeffrey Burton is named as Executive Officer on the Form D that Halia Therapeutics, Inc. filed with the SEC on 30 December 2022, one of 5 people that filing names.
David Bearss is named as Executive Officer and Director on the Form D that Halia Therapeutics, Inc. filed with the SEC on 30 December 2022, one of 5 people that filing names.
Jared Bearss is named as Director on the Form D that Halia Therapeutics, Inc. filed with the SEC on 30 December 2022, one of 5 people that filing names.
John Kauwe is named as Director on the Form D that Halia Therapeutics, Inc. filed with the SEC on 30 December 2022, one of 5 people that filing names.
Jim Savas is named as Director on the Form D that Halia Therapeutics, Inc. filed with the SEC on 30 December 2022, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2022-12-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
- 5 people named on the filing — 2 holding an executive role and 3 as directors only.
No investor is drawn from a Form D — the form states how many invested and never who.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Halia Therapeutics, Inc.
- Source Check — verify Jeffrey Burton's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Jeffrey Burton for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Halia Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Halia Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.